YahooAugust 11, 2026 at 7:00 AM NY24 days ago

IDEXX Expands Catalyst Platform into Cardiac Disease with First and Only Dual-Species Point-of-Care NT-proBNP Test

WESTBROOK, Maine, August 11, 2026--IDEXX announces Catalyst™ proBNP Test, the first and only dual-species, in-clinic diagnostic assay for cardiac assessment.

Read the Full Story at the Source

The summary here comes from the news provider; the rest of the article lives on the publisher's site — Yahoo

Read at Source

Companies in This Story

IDXXIDEXX Laboratories Inc535.38+ 1.15%

Companies in This Story

Related Stories